Medico Intercontinental Limited disclosed that its Promoter and Managing Director, Samir Dilipkumar Shah, has increased his stake in the company through open market purchases. The acquisition of 1,36,886 equity shares took place between June 3 and June 24, 2026, as per a regulatory filing submitted on June 25, 2026. The disclosure was made in compliance with Regulation 7(2) read with Regulation 6(2) of the SEBI (Prohibition of Insider Trading) Regulations, 2015.

Following the transaction, Shah's total shareholding in the company rose to 47,76,999 equity shares, which constitutes 47.77% of the paid-up share capital. Prior to the acquisition, he held 46,40,113 shares, accounting for 46.40% of the company. The shares were acquired exclusively on the BSE.

Details of Acquisition

The table below outlines the specific transactions executed by the promoter during the specified period:

The filing confirmed that there were no transactions in derivatives by the promoter during this period. The company stated that the value of the transactions excludes taxes, brokerage, and other charges. Puneeta Sharma, Company Secretary and Compliance Officer, submitted the disclosure to the stock exchanges.

medico intercontinental has released its audited financial results for the quarter and year ended March 31, 2026. The Board of Directors approved the results during a meeting held on May 22, 2026. The company reported a decline in standalone net profit for the full year, while consolidated figures reflected a shift to a net loss position.

Standalone Financial Performance

For the financial year ended March 31, 2026, the company reported a total revenue of ₹5680.62 lakh, compared to ₹6763.75 lakh in the previous year. Total expenses for the year stood at ₹5368.98 lakh, lower than the ₹6406.20 lakh recorded in the prior year. The net profit for the period after tax was ₹218.36 lakh, a decrease from ₹256.58 lakh in the corresponding period of the previous year.

In the quarter ended March 31, 2026, the standalone net profit after tax was ₹42.41 lakh. Revenue from operations for the quarter was ₹1582.34 lakh, and total expenses amounted to ₹1582.23 lakh.

Consolidated Financial Results

On a consolidated basis, the group reported a total revenue of ₹8535.45 lakh for the year ended March 31, 2026, down from ₹9573.23 lakh in the previous year. Total expenses increased to ₹9469.49 lakh from ₹8891.12 lakh. The group recorded a net loss of ₹1098.04 lakh for the current year, contrasting with a net profit of ₹505.73 lakh in the previous year.

For the quarter ended March 31, 2026, the consolidated net loss was ₹233.25 lakh. Revenue from operations for the quarter was ₹2248.53 lakh, while total expenses were ₹2415.11 lakh.

Key Financial Metrics

The following table summarizes the key standalone financial figures for the year:

Board Decisions

In addition to the financial results, the Board approved the re-appointment of M/s. MJV & Co, Chartered Accountants, Ahmedabad as the Internal Auditor of the company for the financial year 2026-27. The Board also approved various corporate policies for disclosure on the company's website.